GLP1

Business

Amazon launches GLP-1 weight loss program, promising ‘fast, convenient’ access

Amazon GLP-1 treatment Source: Amazon Inc. Amazon is pushing deeper into the booming weight loss market, unveiling Tuesday a new

Read More
Business

Novo Nordisk’s explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight

After years of trying to lose weight “the right way,” Jane Zuckerman realized that “putting in the work just wasn’t

Read More
Business

FDA approves Eli Lilly’s GLP-1 pill, opening the next phase of the weight loss drug market

The U.S. Food and Drug Administration has approved Eli Lilly’s GLP-1 pill, the company said, a major milestone for the

Read More
Business

Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4,

Read More
Earnings

We’re raising our price target on Eli Lilly as the GLP-1 leader delivers a huge beat

Eli Lilly ‘s fourth-quarter results blew past Wall Street estimates on Wednesday, as key GLP-1 drugs, Mounjaro for diabetes and

Read More
Business

First GLP-1 pill for obesity from Novo Nordisk launches in the U.S. 

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of

Read More
Business

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of

Read More
Earnings

Eli Lilly’s big GLP-1 investment — plus, what we want from 4 portfolio stock earnings

Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a

Read More

Get The Latest Investing Tips
Straight to your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.